Rebound hypersomnolence, stimulant abuse, and DAT-mediated dopamine release.
Nishino
Seiji
S
Sleep and Circadian Neurobiology Laboratory, Center for Narcolepsy, Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Palo Alto, CA 94304, USA. nishino@stanford.edu
D000661:Amphetamine / Q000494:pharmacology; D000697:Central Nervous System Stimulants / Q000494:pharmacology*; D006970:Disorders of Excessive Somnolence / Q000209:etiology*; D015259:Dopamine Agents / Q000494:pharmacology*; D050483:Dopamine Plasma Membrane Transport Proteins / Q000502:physiology*; D006801:Humans; D019966:Substance-Related Disorders / Q000150:complications*; D014851:Wakefulness / Q000187:drug effects*
D000697:Central Nervous System Stimulants; D015259:Dopamine Agents; D050483:Dopamine Plasma Membrane Transport Proteins; D000661:Amphetamine